Aynechi Tiba
SEC CIK 1669220 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MBX | MBX Biosciences, Inc. | Dir | 2.14M | $12.00M | — | 2 | 2024-09-16 | 2024-09-16 |
Most active insiders at MBX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FHMLS X, L.P. | 10% | $12.00M | — |
| 2 | Azoulay Salomon | Chief Medical Off | — | $2.72M |
| 3 | Hawryluk P. Kent | Pres, CEO, Dir | $798.4K | $17.9K |
| 4 | Hoerter Steven L. | Pres, CEO, Dir | $265.0K | — |
| 5 | Bartram Richard | CFO | — | — |
| 6 | Smither John W | CFO | — | — |
Aynechi Tiba made no open-market trades at MBX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-09-17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Aynechi Tiba | Dir | P - Purchase | $16.00 | +750.0K | 2.14M | +54% | +$12.00M |
| DI | 2024-09-17 | 2024-09-16 | MBX | MBX Biosciences, Inc. | Aynechi Tiba | Dir | C - Cnv Deriv | — | +1.39M | 1.39M | New | — |
Purchase Sale Sale after option exercise All abbreviations